DMI Medical Supply Co., Inc.

Also known as: DMI Medical Supply · DMI (informal) · MX3 manufacturer · DMIRIE (facility name — possibly acronym)

Definition

DMI Medical Supply Co., Inc. is a Philippine medical supply and dietary supplement company headquartered at the DMIRIE Center, J.P. Cabaguio Avenue, Davao City. The company is best known as the manufacturer of MX3, a line of dietary supplements derived from Garcinia mangostana (mangosteen). Founded on Christian principles, DMI markets its products through official retail channels, e-commerce, and partnerships with Philippine drugstore chains. (MX3 Philippines)

Identities

Source Type	Identity
Wikipedia	N/A
Wikidata	N/A
DBpedia	N/A
ProductOntology	N/A
Wiktionary	N/A
Library of Congress Subject Headings (LCSH)	DMI Medical Supply Co., Inc.
MeSH	N/A
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	N/A
ConceptNet	N/A
OpenCyc	N/A

Also Known As

DMI Medical Supply
DMI (informal)
MX3 manufacturer
DMIRIE (facility name — possibly acronym)

Examples and Analogies

Faith-driven Philippine enterprise: DMI is part of a segment of Philippine businesses founded explicitly on religious principles — similar in orientation to some Catholic or Protestant-led businesses in the country, where company mission and brand messaging reference biblical foundations.
Regional anchor: DMI’s Mindanao headquarters in Davao City situates it as one of the more recognized consumer health brands from the southern Philippines, where most major Philippine FMCG companies are headquartered in Metro Manila.
Product portfolio examples:
MX3 Capsule (500 mg mangosteen, 30-capsule box)
MX3 Plus Capsule (with added L-Carnitine and CoQ10)
MX3 Coffee Mix
MX3 Whitening (personal care line)

Usage Scenarios

1. Retail Consumer Purchase

Consumers purchase MX3 products at Philippine drugstore chains (Watsons, South Star, Mercury Drug), official MX3 retail stores, or via the official e-commerce platform mx3.shop.

2. Online Direct Ordering

DMI operates direct-to-consumer sales through mx3.shop and mx3ph.com, offering nationwide shipping and product information. (MX3 Philippines)

3. International Distribution

MX3 products are exported to Filipino communities abroad and through international e-commerce platforms, leveraging the Philippine diaspora market.

4. Wholesale and Pharmacy Partnerships

DMI supplies MX3 products to major Philippine pharmacy chains for retail distribution, requiring FDA-compliant labeling and distribution documentation.

Strategies

For consumers: verify FDA registration status of any DMI product via the FDA verification portal before purchase.
For potential partners and resellers: contact DMI through official channels for wholesale terms and authorized reseller status.
For researchers: DMI’s published marketing claims and citations should be cross-referenced against independent peer-reviewed literature.
For investors or acquirers: DMI is a privately held company; financial data is not publicly disclosed.

Security and Safety Measures

Beware of counterfeit MX3 products in informal retail channels — verify packaging integrity, security seals, and batch numbers.
Confirm FDA Philippines registration for any DMI product via verification.fda.gov.ph.
Report adverse reactions to FDA Philippines through the official pharmacovigilance channel.
For B2B engagement, verify counterparties via official DMI contact details published on mx3ph.com.

Historical Context

DMI Medical Supply Co., Inc. is headquartered in Davao City, Philippines. The company’s MX3 product line was among its earliest commercial offerings, building on regional mangosteen cultivation in Mindanao (one of the world’s primary mangosteen production regions). The company has been marketing MX3 products in the Philippines since the early 2010s through television, radio, and increasingly online channels. DMI’s branding references biblical principles in its corporate communications. As of 2026, DMI’s founding date and founder names are not prominently disclosed in public corporate communications; the SEC Philippines corporate registry is the authoritative source for verified corporate data. (MX3 Philippines)

Challenges and Controversies

Marketing vs Regulatory Compliance

As a dietary supplement manufacturer, DMI operates under Philippine FDA regulations that prohibit therapeutic claims for supplements. The historical marketing of MX3 has occasionally approached or crossed the line of therapeutic-claim language, a tension common in the Southeast Asian supplement industry.

Clinical Evidence Limitations

DMI’s marketing references a 2014 study by Rodriguez et al. (Journal of Aging Research & Clinical Practice) on knee discomfort benefits of MX3. This study could not be independently verified in PubMed as of June 2026 and warrants appropriate skepticism pending independent replication.

Founder/Corporate Transparency

DMI does not prominently disclose founding date, founder identities, or financial data in public communications — typical of privately held Philippine companies but a limitation for journalistic or research purposes.

Counterfeit Products

The popularity of MX3 has led to counterfeit products in informal retail channels, requiring consumer vigilance and FDA verification.

Geographic Branding

DMI’s Mindanao headquarters provides regional branding authenticity (proximity to mangosteen cultivation) but also limits visibility compared to Metro Manila-headquartered competitors.

References

MX3 Philippines — Official Website (DMI Medical Supply Co., Inc.)